BBIO
Dachille Douglas A., BBIO's Director, spent $79.6K of their own money on 5,000 shares at $16, growing their stake 100%.
+$79.6K
5,000 sh @ $16
BBIO
BridgeBio Pharma, Inc.
SEC CIK 1743881
$67.39
−6.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$19.38M
41 open-market
Net insider flow
−$19.38M
Net selling
Filings shown
134
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at BBIO have sold a net $19.38M of stock (0 open-market buys vs 41 sells).
Largest recent trade: Homcy Charles J sold $8.79M of BBIO, trimming their stake 16%.
Most active filer: Kumar Neil, with 80 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for BBIO, newest firstBBIO
Dachille Douglas A., BBIO's Director, spent $84.1K of their own money on 5,000 shares at $17, opening a brand-new position.
+$84.1K
5,000 sh @ $17
BBIO
−$733.3K
13,777 sh @ $53
BBIO
−$967.4K
14,928 sh @ $65
BBIO
−$2.98M
45,473 sh @ $65
Advertisement
BBIO
−$1.76M
27,105 sh @ $65
BBIO
−$190.4K
2,895 sh @ $66
BBIO
−$420.5K
10,256 sh @ $41
BBIO
−$380K
10,000 sh @ $38
BBIO
−$682.5K
18,200 sh @ $38
BBIO
−$2.41M
65,661 sh @ $37
BBIO
−$576.9K
15,396 sh @ $37
BBIO
−$720K
20,000 sh @ $36
BBIO
−$350K
10,000 sh @ $35
Advertisement
About BBIO insider activity
This page tracks every recent Form 4 filed for BridgeBio Pharma, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is BBIO insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for BridgeBio Pharma, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.